Healthcare - Sector
Galera Therapeutics's activity chart (see below) currently has 16 price targets and 26 ratings on display.
Analysts' price targets on this stock were met 30% of the time, taking 35.4 days on average.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023. First documented stock forecast 02-Dec-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Aug-2023
$80
3 years 2 months 24 days ago
(29-Aug-2023)
0/3 (0%)
$15.56 (24.15%)
Buy Since 16-Dec-2021
$60
3 years 3 months 6 days ago
(16-Aug-2023)
0/3 (0%)
$9.9 (19.76%)
Buy Since 21-Feb-2023
$100
$1200
3 years 3 months 12 days ago
(10-Aug-2023)
0/3 (0%)
$28 (38.89%)
Sell Since 16-Feb-2023
$400
3 years 9 months 6 days ago
(16-Feb-2023)
3/3 (100%)
$76 (23.46%)
39
Hold Since 11-Nov-2020
$3000
$1800
5 years 11 months 6 days ago
(16-Dec-2020)
1/2 (50%)
$808 (36.86%)
138
What is GRTX (Galera Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GRTX (Galera Therapeutics)?
Which analyst has the lowest performance score on GRTX (Galera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GRTX (Galera Therapeutics)?
Which analyst is the currently most bullish on GRTX (Galera Therapeutics)?
Which analyst is the currently most reserved on GRTX (Galera Therapeutics)?